Elicio Therapeutics

Public

Boston, MassachusettsHealthcarehttps://www.elicio.com

Elicio Therapeutics is now publicly traded

The data on this page reflects Elicio Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Private Placement

Jan 5, 2024

Total Funding Raised

$7.05M

Company Overview

Elicio Therapeutics (NAS: ELTX) is a biotechnology company specializing in the development of innovative cancer immunotherapies aimed at patients with limited treatment options and poor outcomes.

Sector

Healthcare

AI Layer

Non-AI

Keywords

Amphiphile (AMP) platformlymph node-targeted immunotherapy deliveryinvestigational off-the-shelf cancer vaccineKRAS-driven cancer vaccinealbumin-binding immunotherapy deliveryT-cell activating cancer therapysolid tumor immunotherapiesminimal residual disease treatmentpancreatic cancer vaccineclinical-stage immunotherapy company

Elicio Therapeutics Comparables

Compare Elicio Therapeutics with similar companies based on industry and business-model similarity.

Elicio Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Nouscom	76%
Immunomic Therapeutics	76%
Treme Bio	73%

View all Comparables

Elicio Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Private Placement	Jan 5, 2024

View all Funding Rounds

Elicio Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Elicio Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersBoston, Massachusetts

Employee Range45

Year Founded2011

Last FundingJan 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?